Get the Stockscreener App
1.0096
1.02%
-0.0104
After Hours:
1.01
0.0004
+0.04%
Estrella Immunopharma Inc Stock (ESLA) Forecast
The Estrella Immunopharma Inc (ESLA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.531, representing a -47.41% decrease from the current price of $1.0096. The highest analyst price target is $0.5641, and the lowest is $0.4979.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ESLA Price Target
Average 1.9636
(+94.49% Upside)
Is Estrella Immunopharma Inc (ESLA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 50.50 | Neutral |
| STOCH(9,6) | 59.03 | Neutral |
| STOCHRSI(14) | 69.58 | Neutral |
| MACD(12,26) | 0.000757 | Sell |
| ADX(14) | 10.77 | Neutral |
| William %R | -36.73 | Neutral |
| CCI(14) | 6.2722 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.9959
Buy
|
1.005
Buy
|
| MA20 |
1.0325
Sell
|
1.0071
Buy
|
| MA50 |
0.9703
Buy
|
1.0059
Buy
|
| MA100 |
1.0447
Sell
|
1.0252
Sell
|
| MA200 |
1.0519
Sell
|
1.0566
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, ESLA could be considered a Neutral, with 17 technical analysis indicators signaling 5 Buy signals, 6 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on ESLA, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 50.5 indicates that ESLA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 59.03 indicates that ESLA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 69.58 indicates that ESLA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 10.77 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 6.2722 indicates that ESLA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ESLA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Estrella Immunopharma Inc financial reports and earnings history, Estrella Immunopharma Inc (ESLA) stock could reach $9.5269 by 2030, $17.93 by 2040 and $44.64 by 2050. See the projected annual prices until 2050 of the Estrella Immunopharma Inc stock below:
- Estrella Immunopharma Inc (ESLA) is expected to reach an average price of $13.71 in 2035, with a high prediction of $15.05 and a low estimate of $13.82. This indicates an $1,258% rise from the last recorded price of $1.0096.
- Estrella Immunopharma Inc (ESLA) stock is projected to chart a bullish course in 2040, with an average price target of $16.40, representing an $1,524% surge from its current level. The forecast ranges from a conservative $16.52 to a sky-high $17.93.
- Our analysts predict Estrella Immunopharma Inc (ESLA) to jump 3,863% by 2045, soaring from $17.41 to an average price of $40.01, potentially reaching $39.11. While $17.41 is the low estimate, the potential upside is significant.
- Estrella Immunopharma Inc (ESLA) stock is expected to climb by 2050, reaching an average of $42.13, a $4,073% jump from its current level. However, a wide range of estimates exists, with high and low targets of $44.64 and $42.13, respectively, highlighting the market's uncertainty.
Estrella Immunopharma Inc Stock (ESLA) Year by Year Forecast
Estrella Immunopharma Inc Stock (ESLA) Price Forecast for 2025
Estrella Immunopharma Inc Stock (ESLA) is expected to reach an average price of $1.3049 in 2025, with a high prediction of $2.3921 and a low estimate of $0.2177. This indicates an +29.25% rise from the last recorded price of $1.0096.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $0.3762 | $0.4979 | $0.5641 | -62.74% |
| August, 2025 | $0.2856 | $0.3382 | $0.2235 | -71.71% |
| September, 2025 | $1.67 | $0.2177 | $0.58 | +65.41% |
| October, 2025 | $2.2302 | $2.3189 | $2.3921 | +120.90% |
| November, 2025 | $1.8444 | $2.1944 | $2.2623 | +82.69% |
| December, 2025 | $2.0746 | $1.9904 | $1.9486 | +105.49% |
Estrella Immunopharma Inc Stock (ESLA) Price Forecast for 2026
The predicted value for Estrella Immunopharma Inc (ESLA) in 2026 is set at an average of $2.2705. Estimates vary from a peak of $3.7095 to a trough of $0.8315, indicating an +124.89% surge from the present price of $1.0096.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.7087 | $1.8288 | $1.9107 | +69.24% |
| February, 2026 | $1.573 | $1.623 | $1.5848 | +55.80% |
| March, 2026 | $1.3772 | $1.4611 | $1.4356 | +36.41% |
| April, 2026 | $0.9675 | $1.0374 | $1.044 | -4.17% |
| May, 2026 | $0.8405 | $0.8315 | $0.8495 | -16.75% |
| June, 2026 | $3.5242 | $3.03 | $3.7095 | +249.07% |
| July, 2026 | $3.3478 | $3.5478 | $3.4731 | +231.60% |
| August, 2026 | $3.1567 | $3.1373 | $2.942 | +212.67% |
| September, 2026 | $2.7303 | $2.9903 | $3.0314 | +170.44% |
| October, 2026 | $2.4892 | $2.6145 | $2.5551 | +146.56% |
| November, 2026 | $2.2431 | $2.2881 | $2.3053 | +122.18% |
| December, 2026 | $1.7318 | $1.8118 | $2.0229 | +71.53% |
Estrella Immunopharma Inc Stock (ESLA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Estrella Immunopharma Inc (ESLA) is $3.8948, with a high forecast of $6.3442 and a low forecast of $1.4454. This indicates an +285.78% increase from the last price of $1.0096.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.4908 | $1.5307 | $1.5866 | +47.66% |
| February, 2027 | $5.2106 | $1.4454 | $5.0268 | +416.11% |
| March, 2027 | $4.8037 | $4.8538 | $4.6838 | +375.81% |
| April, 2027 | $4.3475 | $4.2841 | $4.1773 | +330.61% |
| May, 2027 | $4.1011 | $4.1011 | $4.1143 | +306.21% |
| June, 2027 | $3.4381 | $3.5481 | $3.8445 | +240.54% |
| July, 2027 | $3.2218 | $3.2318 | $3.3115 | +219.11% |
| August, 2027 | $2.6654 | $2.7871 | $3.0452 | +164.01% |
| September, 2027 | $2.2624 | $2.2624 | $2.4488 | +124.09% |
| October, 2027 | $6.5421 | $2.0592 | $5.6421 | +547.99% |
| November, 2027 | $5.9904 | $6.1104 | $6.3442 | +493.35% |
| December, 2027 | $5.4309 | $5.4309 | $5.8946 | +437.92% |
Estrella Immunopharma Inc Stock (ESLA) Price Forecast for 2028
In 2028, Estrella Immunopharma Inc (ESLA) is projected to reach an average price of $5.1673, with a high projection of $7.6615 and a low estimate of $2.6731. This indicates an +411.82% rise from the last price of $1.0096.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.2592 | $5.2693 | $5.1972 | +420.92% |
| February, 2028 | $4.6375 | $4.7576 | $5.0313 | +359.34% |
| March, 2028 | $4.208 | $4.208 | $4.4497 | +316.80% |
| April, 2028 | $3.5964 | $3.7464 | $3.927 | +256.22% |
| May, 2028 | $2.9968 | $3.0768 | $3.3333 | +196.83% |
| June, 2028 | $7.11 | $2.6731 | $6.02 | +604.24% |
| July, 2028 | $7.3231 | $7.4178 | $7.6615 | +625.34% |
| August, 2028 | $6.5169 | $6.8669 | $7.1238 | +545.50% |
| September, 2028 | $6.37 | $6.43 | $6.3185 | +530.94% |
| October, 2028 | $5.7231 | $5.9831 | $6.1608 | +466.87% |
| November, 2028 | $5.1369 | $5.1869 | $5.4839 | +408.81% |
| December, 2028 | $4.60 | $4.7692 | $4.9143 | +355.63% |
Estrella Immunopharma Inc Stock (ESLA) Price Forecast for 2029
The 2029 price forecast for Estrella Immunopharma Inc Stock (ESLA) is $6.7916 on average, with a high prediction of $10.30 and a low estimate of $3.2869. This represents an +572.70% increase from the previous price of $1.0096.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.764 | $3.8339 | $4.0964 | +272.82% |
| February, 2029 | $3.4058 | $3.2869 | $3.5247 | +237.35% |
| March, 2029 | $8.7084 | $8.47 | $8.9789 | +762.55% |
| April, 2029 | $8.4361 | $8.4862 | $8.3778 | +735.58% |
| May, 2029 | $7.5734 | $7.6334 | $7.7456 | +650.14% |
| June, 2029 | $6.9213 | $7.2218 | $7.3629 | +585.55% |
| July, 2029 | $6.239 | $6.349 | $6.6707 | +517.97% |
| August, 2029 | $5.5513 | $5.5963 | $6.0485 | +449.85% |
| September, 2029 | $4.6941 | $4.8541 | $5.2457 | +364.95% |
| October, 2029 | $4.0314 | $4.0713 | $4.4535 | +299.31% |
| November, 2029 | $10.48 | $3.9008 | $10.30 | +938.04% |
| December, 2029 | $9.7972 | $9.8088 | $9.7844 | +870.40% |
Estrella Immunopharma Inc Stock (ESLA) Price Forecast for 2030
Estrella Immunopharma Inc Stock (ESLA) is expected to reach an average price of $8.0641 in 2030, with a high forecast of $11.61 and a low forecast of $4.5146. This signifies an +698.75% surge from the last price of $1.0096.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $8.8495 | $8.8713 | $9.5269 | +776.53% |
| February, 2030 | $8.262 | $8.262 | $8.4457 | +718.34% |
| March, 2030 | $7.4745 | $7.5145 | $7.9201 | +640.34% |
| April, 2030 | $6.8171 | $6.8171 | $7.0127 | +575.22% |
| May, 2030 | $5.7177 | $5.8394 | $6.4721 | +466.33% |
| June, 2030 | $5.0302 | $5.1102 | $5.4159 | +398.24% |
| July, 2030 | $11.90 | $4.5146 | $11.00 | +1,078% |
| August, 2030 | $11.00 | $11.12 | $11.61 | +989.94% |
| September, 2030 | $10.02 | $10.37 | $10.74 | +892.60% |
| October, 2030 | $9.5054 | $9.5155 | $9.7481 | +841.50% |
| November, 2030 | $8.5426 | $8.6627 | $9.1922 | +746.13% |
| December, 2030 | $7.8099 | $7.8599 | $8.2695 | +673.57% |
1.89%
3.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):